125 related articles for article (PubMed ID: 36987767)
1. Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year.
Crvenkova S; Jakimovki D; Ristovski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Mar; 44(1):105-115. PubMed ID: 36987767
[No Abstract] [Full Text] [Related]
2. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
Park JY; Lee YJ; Kim T; Lee CY; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
BMC Cancer; 2020 Oct; 20(1):1040. PubMed ID: 33121456
[TBL] [Abstract][Full Text] [Related]
3. The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment Characteristics of Operated Lung Cancer Patients.
Arak H; Eronat O; Dogan I; Aydin ES; Aytekin A
J Coll Physicians Surg Pak; 2023 Nov; 33(11):1271-1277. PubMed ID: 37926880
[TBL] [Abstract][Full Text] [Related]
4. Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care.
Zhai Y; Chopra P; Kang D; Robert NJ; Zhang W
Curr Oncol; 2023 Jan; 30(1):769-785. PubMed ID: 36661708
[TBL] [Abstract][Full Text] [Related]
5. Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Saw SPL; Zhou S; Chen J; Lai G; Ang MK; Chua K; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Lim DWT; Tan A; Fong KW; Takano A; Cheng XM; Lim KH; Koh T; Ong BH; Tan EH; Toh CK; Skanderup AJ; Tan SH; Tan DSW
JAMA Netw Open; 2021 Nov; 4(11):e2131892. PubMed ID: 34739062
[TBL] [Abstract][Full Text] [Related]
6. Extended Delay to Treatment for Stage III-IV Non-Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic.
Mayne NR; Bajaj SS; Powell J; Elser HC; Civiello BS; Fintelmann FJ; Li X; Yang CJ
Clin Lung Cancer; 2022 Sep; 23(6):e362-e376. PubMed ID: 35660355
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.
Risteski M; Crvenkova S; Atanasov Z; Isjanovska R
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):49-61. PubMed ID: 24566015
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of lung cancer in Denmark during the COVID-19 pandemic.
Olesen TB; Rasmussen TR; Jakobsen E; Engberg H; Hilberg O; Møller H; Jensen JW; Jensen H
Cancer Epidemiol; 2023 Aug; 85():102373. PubMed ID: 37172520
[TBL] [Abstract][Full Text] [Related]
9. Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report.
Mynard N; Saxena A; Mavracick A; Port J; Lee B; Harrison S; Chow O; Villena-Vargas J; Scheff R; Giaccone G; Altorki N
Clin Lung Cancer; 2022 May; 23(3):e238-e242. PubMed ID: 34580031
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
11. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement.
Guckenberger M; Belka C; Bezjak A; Bradley J; Daly ME; DeRuysscher D; Dziadziuszko R; Faivre-Finn C; Flentje M; Gore E; Higgins KA; Iyengar P; Kavanagh BD; Kumar S; Le Pechoux C; Lievens Y; Lindberg K; McDonald F; Ramella S; Rengan R; Ricardi U; Rimner A; Rodrigues GB; Schild SE; Senan S; Simone CB 2nd; Slotman BJ; Stuschke M; Videtic G; Widder J; Yom SS; Palma D
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):631-640. PubMed ID: 32589990
[TBL] [Abstract][Full Text] [Related]
12. Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non-Small Cell Lung Cancer Versus Community Controls.
Arrato NA; Lo SB; Coker CA; Covarrubias JJ; Blevins TR; Reisinger SA; Presley CJ; Shields PG; Andersen BL
J Natl Compr Canc Netw; 2022 Feb; 20(2):118-125. PubMed ID: 35130505
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315).
Sebastian M; Eberhardt WEE; von der Heyde E; Dörfel S; Wiegand J; Schiefer C; Losem C; Jänicke M; Fleitz A; Zacharias S; Kaiser-Osterhues A; Hipper A; Dietel C; Bleckmann A; Benkelmann R; Boesche M; Grah C; Müller A; Griesinger F; Thomas M;
Int J Cancer; 2024 Jun; 154(11):1967-1978. PubMed ID: 38329180
[TBL] [Abstract][Full Text] [Related]
14. Novel Program Offering Remote, Asynchronous Subspecialist Input in Thoracic Oncology: Early Experience and Insights Gained During the COVID-19 Pandemic.
West HJ; Tan YA; Barzi A; Wong D; Parsley R; Sachs T
JCO Oncol Pract; 2022 Apr; 18(4):e537-e550. PubMed ID: 34860558
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
Kocher F; Hilbe W; Seeber A; Pircher A; Schmid T; Greil R; Auberger J; Nevinny-Stickel M; Sterlacci W; Tzankov A; Jamnig H; Kohler K; Zabernigg A; Frötscher J; Oberaigner W; Fiegl M
Lung Cancer; 2015 Feb; 87(2):193-200. PubMed ID: 25564398
[TBL] [Abstract][Full Text] [Related]
16. Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian Perspective.
Agulnik J; Kasymjanova G; Pepe C; Friedmann J; Small D; Sakr L; Wang H; Spatz A; Sultanem K; Cohen V
Curr Oncol; 2024 Mar; 31(3):1562-1571. PubMed ID: 38534952
[No Abstract] [Full Text] [Related]
17. Safety of lung cancer surgery during COVID-19 in a pandemic epicenter.
Villena-Vargas J; Lutton EM; Mynard N; Nasar A; Voza F; Chow O; Lee B; Harrison S; Stiles BM; Port JL; Altorki NK
J Thorac Cardiovasc Surg; 2022 Aug; 164(2):378-385. PubMed ID: 35459540
[TBL] [Abstract][Full Text] [Related]
18. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
Guckenberger M; Belka C; Bezjak A; Bradley J; Daly ME; DeRuysscher D; Dziadziuszko R; Faivre-Finn C; Flentje M; Gore E; Higgins KA; Iyengar P; Kavanagh BD; Kumar S; Le Pechoux C; Lievens Y; Lindberg K; McDonald F; Ramella S; Rengan R; Ricardi U; Rimner A; Rodrigues GB; Schild SE; Senan S; Simone CB 2nd; Slotman BJ; Stuschke M; Videtic G; Widder J; Yom SS; Palma D
Radiother Oncol; 2020 May; 146():223-229. PubMed ID: 32342863
[TBL] [Abstract][Full Text] [Related]
19. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
20. Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).
Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2020 Aug; 146():112-119. PubMed ID: 32526601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
